maxacalcitol and Skin-Neoplasms

maxacalcitol has been researched along with Skin-Neoplasms* in 4 studies

Other Studies

4 other study(ies) available for maxacalcitol and Skin-Neoplasms

ArticleYear
Successful etretinate treatment of recurrent keratoacanthomas on a skin graft: Case report.
    The Journal of dermatology, 2017, Volume: 44, Issue:2

    Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents; Calcitriol; Dermatologic Surgical Procedures; Drug Resistance, Neoplasm; Etretinate; Female; Humans; Keratoacanthoma; Keratolytic Agents; Leg; Neoplasm Recurrence, Local; Ointments; Skin; Skin Neoplasms; Skin Transplantation; Transplants; Treatment Outcome

2017
Successful treatment of Bowen's disease with topical maxacalcitol.
    Acta dermato-venereologica, 2012, Volume: 92, Issue:6

    Topics: Administration, Cutaneous; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Bowen's Disease; Calcitriol; Humans; Immunohistochemistry; Male; Membrane Proteins; Skin Neoplasms; Treatment Outcome

2012
Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1alpha, 25-dihydroxy-22-oxacalcitriol) in 17 patients.
    The Journal of dermatology, 2007, Volume: 34, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Calcitriol; Child; Child, Preschool; Dermatologic Agents; Female; Humans; Male; Skin Neoplasms; Treatment Outcome; Warts

2007
A case of maxacalcitol-resistant confluent and reticulated papillomatosis successfully treated with minocycline.
    The Journal of dermatology, 2006, Volume: 33, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Calcitriol; Dermatologic Agents; Drug Resistance; Female; Humans; Minocycline; Papilloma; Skin Neoplasms

2006